United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

formula b) 128ml standard tube (alliance healthcare (distribution) ltd - sodium dihydrogen phosphate dihydrate; disodium hydrogen phosphate dodecahydrate - enema - 100mg/1ml ; 80mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

formula b) 128ml long tube (a a h pharmaceuticals ltd - sodium dihydrogen phosphate dihydrate; disodium hydrogen phosphate dodecahydrate - enema - 100mg/1ml ; 80mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

formula b) 128ml standard tube (a a h pharmaceuticals ltd - sodium dihydrogen phosphate dihydrate; disodium hydrogen phosphate dodecahydrate - enema - 100mg/1ml ; 80mg/1ml

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults. peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   gastric retention -   ileus -   toxic colitis or toxic megacolon -   hypersensitivity to any ingredient in peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution [see warnings and precautions (5.10)] risk summary there are no available data on peg-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution in pregnant women to inform a drug-associated risk for adverse developmental

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

formula b) 128ml standard tube (medihealth (northern) ltd - sodium dihydrogen phosphate dihydrate; disodium hydrogen phosphate dodecahydrate - enema - 100mg/1ml ; 80mg/1ml

United States - English - NLM (National Library of Medicine)

unit dose services - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see warnings; gastrointestinal bleeding, ulceration, and perforation ). diclofenac is indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis - for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to diclofenac or any components of the drug product ( see warnings; anaphylactic reactions, serious skin reactions ). - history of asthma, urticaria, or other allergic-type reactions after takin

Australia - English - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

United States - English - NLM (National Library of Medicine)

hospira, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml - 23.4% sodium chloride injection, usp is indicated for use as an electrolyte replenisher in parenteral fluid therapy. it serves as an additive for total parenteral nutrition (tpn) and as an additive for carbohydrate containing i.v. fluids. 23.4% sodium chloride injection, usp additive solution is contraindicated in patients with hypernatremia or fluid retention.

United States - English - NLM (National Library of Medicine)

reliable 1 laboratories llc - sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - sodium bicarbonate 648 mg - purpose antacid uses relieves - acid indigestion - heartburn - sour stomach - upset stomach associated with these symptoms

United States - English - NLM (National Library of Medicine)

reliable 1 laboratories llc - sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37) - sodium bicarbonate 324 mg - purpose antacid uses relieves - acid indigestion - heartburn - sour stomach - upset stomach associated with these symptoms